Latest Breaking News On - விஞ்ஞானி பத்திரிகை - Page 1 : comparemela.com

Published: May 18, 2021 IsoPlexis adds Switzerland as the latest country with access to their unique functional single-cell proteomics platform, adding to their existing partnerships across Asia and Europe. BRANFORD, Conn., May 18, 2021 /PRNewswire/ IsoPlexis, the leader in single-cell proteomics, today announced an exclusive agreement with Bucher Biotec AG, a Swiss distributor company representing some of the most advanced US, European, and Asian manufacturers of highly innovative life science research instrumentation, associated reagents, and consumables. This agreement follows IsoPlexis recent global distributor announcements, throughout Asia and Europe. IsoPlexis IsoLight platform has received numerous awards, recognized as both The Scientist s and Fierce Life Science s #1 innovation for the ability to provide single-cell sensitivity with highly multiplexed and quantitative functional ELISA detection together for the first time. IsoPlexis IsoLight was awarded the

South koreaJon chenPeter sieselBucher biotecIsoplexi isolightPrnewswire isoplexisPlexi isolightFierce life scienceRed dot design awardRed dot design awardsHigh design qualityChief commercialScientist magazineRed dotSoplexis partners with bucher biotec to expand into switzerland marketதெற்கு கொரியா